Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
September 30, 2024 11:29 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
Global Gastrointestinal Drugs Market Report (2021 to 2030) - COVID-19 Implications and Growth
May 10, 2021 05:53 ET
|
Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....
Medical Abortions Four Times as Risky as Surgical, Reports the Journal of American Physicians and Surgeons
December 18, 2019 12:33 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Abortion providers are encouraging women to choose the medical abortion option, but studies consistently show that the rate of complications is four...